Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Suppression of <i>ABHD2</i>, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer

13 Jun 2016

Abstract excerpt

// Koji Yamanoi 1 , Noriomi Matsumura 1 , Susan K. Murphy 2 , Tsukasa Baba 1 , Kaoru Abiko 1 , Junzo Hamanishi 1 , Ken Yamaguchi 1 , Masafumi Koshiyama 1 , Ikuo Konishi 1 , Masaki Mandai 3 1 Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto, Japan 2 Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, USA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to MicroRNA in disease regulation
Share to Ovarian cancer diagnosis and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27323405
DOI: 10.18632/oncotarget.9951

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Suppression of <i>ABHD2</i>, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancerPMID 27323405Read ↗

Pooled Genomic Screens Identify Anti-apoptotic Genes as Targetable Mediators of Chemotherapy Resistance in Ovarian CancerSemantic proximity Read ↗

Mechanisms of Drug Resistance in Ovarian Cancer and Associated Gene TargetsSemantic proximity Read ↗

Anoikis resistance in Cancer: Mechanisms, therapeutic strategies, potential targets, and models for enhanced understandingSemantic proximity Read ↗

Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell linesSemantic proximity Read ↗

TOP2A is a potential biomarker and promotes platinum drug resistance in ovarian cancer: a bioinformatics and experimental analysisSemantic proximity Read ↗

Unveiling drug resistance pathways in high-grade serous ovarian cancer(HGSOC): recent advances and future perspectivesSemantic proximity Read ↗

MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistanceSemantic proximity Read ↗

Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian carcinomaSemantic proximity Read ↗

Comprehensive analysis of hub genes associated with cisplatin-resistance in ovarian cancer and screening of therapeutic drugs through bioinformatics and experimental validationSemantic proximity Read ↗

Effect of ALDH1A1 Gene Knockout on Drug Resistance in Paclitaxel and Topotecan Resistant Human Ovarian Cancer Cell Lines in 2D and 3D ModelSemantic proximity Read ↗

Whole–genome characterization of chemoresistant ovarian cancerSemantic proximity Read ↗

Analysis of the expression and clinical significance of miR-382-5P in ovarian cancer based on biological informationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.